Microbot Medical Inc. Files 8-K: Material Agreement & Equity Sales
Ticker: MBOT · Form: 8-K · Filed: Jan 7, 2025 · CIK: 883975
| Field | Detail |
|---|---|
| Company | Microbot Medical Inc. (MBOT) |
| Form Type | 8-K |
| Filed Date | Jan 7, 2025 |
| Risk Level | medium |
| Pages | 6 |
| Reading Time | 7 min |
| Key Dollar Amounts | $0.01, $1.75, $7.0 million, $25,000, $35,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, 8-k
Related Tickers: MBOT
TL;DR
Microbot Medical (MBOT) filed an 8-K detailing a new material agreement and equity sales.
AI Summary
Microbot Medical Inc. announced on January 6, 2025, that it entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and other events. The filing includes financial statements and exhibits.
Why It Matters
This 8-K filing indicates significant corporate activity for Microbot Medical Inc., including a new material agreement and equity transactions, which could impact its financial standing and future operations.
Risk Assessment
Risk Level: medium — The filing involves material definitive agreements and unregistered sales of equity, which can introduce financial and operational risks.
Key Players & Entities
- Microbot Medical Inc. (company) — Registrant
- January 6, 2025 (date) — Date of earliest event reported
FAQ
What is the nature of the material definitive agreement entered into by Microbot Medical Inc.?
The filing states that Microbot Medical Inc. entered into a material definitive agreement on January 6, 2025, but the specific details of this agreement are not provided in the excerpt.
What type of equity securities were sold unregistered?
The filing mentions unregistered sales of equity securities, but the specific type and amount of securities are not detailed in the provided text.
What are the key financial statements and exhibits included in this filing?
The filing indicates that financial statements and exhibits are included, but their specific content is not detailed in the excerpt.
When was Microbot Medical Inc. incorporated and in which state?
Microbot Medical Inc. was incorporated in Delaware.
What is the business address and phone number for Microbot Medical Inc.?
The business address is 288 Grove Street, Suite 388, Braintree, MA 02184, and the business phone number is 908-938-5561.
Filing Stats: 1,746 words · 7 min read · ~6 pages · Grade level 11.4 · Accepted 2025-01-07 09:00:30
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value MBOT NASDAQ Capital Mark
- $1.75 — Common Stock"), at an offering price of $1.75 per share, for aggregate gross proceeds
- $7.0 million — ngs (as defined below) of approximately $7.0 million before deducting the placement agent fe
- $25,000 — Offerings, a non-accountable expense of $25,000, up to $35,000 for its fees and expense
- $35,000 — n-accountable expense of $25,000, up to $35,000 for its fees and expenses of legal coun
- $15,950 — fees and expenses of legal counsel and $15,950 for clearing expenses. The Company has
- $2.1875 — issuance, and have an exercise price of $2.1875 per share. Further, pursuant to the Eng
Filing Documents
- form8-k.htm (8-K) — 54KB
- ex4-1.htm (EX-4.1) — 124KB
- ex4-2.htm (EX-4.2) — 125KB
- ex5-1.htm (EX-5.1) — 13KB
- ex10-1.htm (EX-10.1) — 265KB
- ex99-1.htm (EX-99.1) — 14KB
- ex5-1_001.jpg (GRAPHIC) — 8KB
- 0001493152-25-001133.txt ( ) — 901KB
- mbot-20250106.xsd (EX-101.SCH) — 3KB
- mbot-20250106_lab.xml (EX-101.LAB) — 33KB
- mbot-20250106_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MICROBOT MEDICAL INC. /s/ Harel Gadot Harel Gadot Chairman, President and Chief Executive Officer Date: January 7, 2025